Akmyglin™ Amygdalin

Product:    Huperzine ACAS No.:    102518-79-6
Molecular Formula:    C15H18N2O
Molecular Weight:    242.3162 g/mol
Specification:    1%; 5%; 99%min

• Product:    Morin • CAS No.:    480-16-0 • Molecular Formula:    C15H10O7 • Molecular Weight:    302.235700 g/mol • Specification:    98%min by HPLC

• Product:    N-Acetyltizanidine • CAS No.:    173532-15-5 • Molecular Formula:    C11H10ClN5OS • Molecular Weight:    295.748 g/mol • Specification:    98%min by HPLC

• Product:    Puerarin • CAS No.:    3681-99-0 • Molecular Formula:    C21H20O9 • Molecular Weight:    416.3781 • Specification:    98%min

Rifapentine is an antibiotic drug used in the treatment of tuberculosis. It inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme.

• Product:    Salidroside • CAS No.:    10338-51-9 • Molecular Formula:    C14H20O7 • Molecular Weight:    300.3044g/mol • Specification:    98%min by HPLC

CAS No.:    84687-43-4Molecular Formula:    C41H68O14
Molecular Weight:    784.9702 g/mol
Plant Source:    Astragalus membranaceus
Specification:    0.2%, 0.5%, 1%, 5%,10%, 30%; 50% 70%; 90% and 98%...

Product:    Q-Amply™ QS 21 CAS No.:    141256-04-4Molecular Formula:    C92H148O46Molecular Weight:    1990.13g/molSpecification:    90%min; 95%min

• Q-Amply™ QS-21 • Q-Amply™ Quil A • QS-7 | QS-17 | QS-18 (In Development Series)

• Product:    Cepharanthine • CAS No.:    481-49-2 • Molecular Formula:    C37H38N2O6 • Molecular Weight:    606.71 • Specification:    98%min by HPLC or as requested

• Specification:    98% min by HPLC • Availability:    API Development Available upon request • Application:    HIV p24 capsid protein（HIV P24）

• Product:    Triptolide • CAS No.:    38748-32-2 • Molecular Formula:    C20H24O6 • Molecular Weight:    360.4010g/mol • Specification:    99%min by HPLC

AKTINPHARM® Pharmaceutical—From Small Molecules to Complex Delivery, Bridging the Critical Path from Innovative Drug Discovery to Commercialization.